Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...

A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that will make the kidney disease drug developer the first U.S. biotech ...

Pimco, one of the world’s largest bond managers, owns 354 million Class A shares of Venture Global (VG), the natural-gas exporter that went ...

Shares in Venture Global are expected to make their debut on the New York Stock Exchange after the company raised $1.75 ...

Bond manager’s $7 billion stake in Venture Global latest sign that traditional asset managers are making inroads investing in ...

Flexituff Ventures International Limited was originally constituted as a partnership firm under the Indian Partnership Act, 1932 on January 22, 1966 under the name and style of Saurabh Potteries ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

What Budget 2025 can do to power India's GCC surge Budget 2025: Global Capability Centers (GCCs) have evolved into significant contributors to India's GDP. The upcoming Budget might play a crucial ...

Jaiprakash Power Ventures Ltd., incorporated in the year 1994, is a Small Cap company (having a market cap of Rs 10,780.49 Crore) operating in Power sector. Jaiprakash Power Ventures Ltd. key Products ...

Tekmar Group has announced a significant new contract award with a total value in the region of £5 million for a UK-based offshore wind farm project. In this special Spotlight interview, Jessica Casey ...